Globus Medical (GMED) Free Cash Flow Growth (3y) (2014 - 2026)
Analysis
Globus Medical (GMED) Free Cash Flow Growth (3y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.74 Bn | 175.14 Bn | 7.27 Bn | 41.96% |
| 2 | Intuitive Surgical | 127.56 Bn | 122.34 Bn | 1.96 Bn | 24.84% |
| 3 | Medtronic | 116.90 Bn | 108.08 Bn | 6.34 Bn | 35.29% |
| 4 | Stryker | 103.85 Bn | 100.37 Bn | 4.50 Bn | 25.48% |
| 5 | Boston Scientific | 63.70 Bn | 63.16 Bn | 3.85 Bn | 35.42% |
| 6 | Edwards Lifesciences | 49.88 Bn | 45.63 Bn | 1.35 Bn | 250.09% |
| 7 | Alcon | 33.04 Bn | 31.59 Bn | 1.68 Bn | 11.09% |
| 8 | Dexcom | 32.18 Bn | 30.23 Bn | 830.00 Mn | 12.01% |
| 9 | Steris | 20.65 Bn | 20.17 Bn | 684.20 Mn | 9.23% |
| 10 | Globus Medical | 10.01 Bn | 9.42 Bn | 548.17 Mn | 117.50% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 117.50% |
| Mar 31, 2026 | 63.37% |
| Dec 31, 2025 | 64.30% |
| Sep 30, 2025 | 116.98% |
| Jun 30, 2025 | 33.59% |
| Mar 31, 2025 | 78.76% |
| Dec 31, 2024 | 48.33% |
| Sep 30, 2024 | 39.58% |
| Jun 30, 2024 | -19.54% |
| Mar 31, 2024 | -21.85% |
| Dec 31, 2023 | 7.35% |
| Sep 30, 2023 | -6.94% |
| Jun 30, 2023 | 9.38% |
| Mar 31, 2023 | 23.16% |
| Dec 31, 2022 | 5.82% |
| Sep 30, 2022 | -21.81% |
| Jun 30, 2022 | 18.67% |
| Mar 31, 2022 | 30.79% |
| Sep 30, 2021 | -2.19% |
| Jun 30, 2021 | 40.10% |